Welcome to Kidney Week 2018 in beautiful San Diego

This is an exciting time in nephrology with new innovations and insights offering promise for the advancement of kidney care, especially in the areas of artificial intelligence and connected home therapies. We hope you’ll experience the many businesses, researchers and clinical experts that Fresenius Medical Care proudly features at this year’s conference, along with our 71 abstracts in oral and poster presentations.

Fresenius Medical Care is committed to translating science into practice and embraces innovation across our network of dialysis centers, outpatient cardiac and vascular

labs, urgent care centers, and specialty pharmacy and laboratory services. We appreciate the opportunity to share insights from our work to help improve the lives of every patient, every day.

Frank W. Maddux, MD, FACP
Chief Medical Officer,
Executive Vice President of Clinical and Scientific Affairs
Fresenius Medical Care North America

Stop by for a Chat


Fresenius Kidney Care, a division of FMCNA, provides dialysis treatment and services to more than 180,000 patients with kidney disease at more than 2,400 centers nationwide. Fresenius Kidney Care supports people by helping address both the physical and emotional aspects of kidney disease through personalized care, education and lifestyle support services so they can lead meaningful and fulfilling lives. For more information, visit www.freseniuskidneycare.com.



Through two divisions — Renal Technologies and Renal Pharmaceuticals — FMCNA delivers hemodialysis and peritoneal dialysis equipment, as well as renal pharmaceuticals, in support of clinical and home environments.



Renal Research Institute is a unique research organization that stands at the forefront of medical research in chronic kidney disease, particularly in patients undergoing renal replacement therapies. It has been a leading force behind landmark studies on hemodialysis and has a solid and successful partnership with national and international academic institutions. Its research spans a full spectrum of interests from molecular biology and clinical research to epidemiology. RRI hosts a distinguished annual International Conference on Dialysis and trains research fellows from more than 30 countries around the world.



Frenova Renal Research is the world’s only drug and medical device contract clinical development services provider dedicated exclusively to renal research. As an FMCNA company, Frenova manages a networked system of clinical research assets and resources, including over 450 principal investigators at more than 260 sites, representing 160 medical practices and nearly 700 dialysis centers. Frenova manages clinical trials in kidney disease and adjacent medical conditions.


Acumen Physician Solutions develops and delivers intuitive software tools to assist nephrologists in the practice of medicine. Our nephrology-specific products include: Acumen 2.0 Powered by Epic, Acumen Revenue Cycle Management, Acumen Mobile Charge Capture, Acumen Nephrologixx, and Acumen PQRS.


Spectra Laboratories, an FMCNA company, delivers renal-specific testing, analysis and reporting with the reliability you require to ensure the best outcomes possible for your patients. Our team of clinical experts, paired with our patient-centric tools and resources, help you comply with industry guidelines.


We are committed to the highest level of patient care and quality across our entire portfolio of products and services as we develop a more personalized experience to improve outcomes.

Bill Valle, CEO, Fresenius Medical Care North America (FMCNA)

What's Trending on Twitter